|
Resolution: standard / high Figure 4.
Percentages of apoptotic CP-18821 Barrett's esophagus-derived cells after treatment with FXR (4A) or VDR (4B) ligands, as measured by flow cytometry.
De Gottardi et al. Molecular Cancer 2006 5:48 doi:10.1186/1476-4598-5-48 |